Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Denies Breaking Trade Truce as U.S.-China Tensions Escalate

by Team Lumida
June 2, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Manufacturing Powerhouse Faces Domestic Struggles: What It Means for Global Investors

"MY ROAD : FLAG OF CHINA" by Lαin is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China rejected President Trump’s accusations of violating a trade truce, claiming it upheld the Geneva consensus while accusing the U.S. of undermining the agreement with restrictive measures.
  • Tensions have flared over issues such as U.S. export controls on AI chips, visa restrictions for Chinese students, and China’s rare-earth mineral exports.
  • Trump reiterated his accusations, stating he plans to discuss the matter with Chinese President Xi Jinping.
  • The breakdown in progress toward a deal has rattled markets, with Hong Kong’s Hang Seng Index falling 2.2% and the Hang Seng Tech Index dropping 2.4%.

What Happened?

China’s Commerce Ministry pushed back against President Trump’s claims that Beijing violated a trade truce reached in mid-May during talks in Geneva. The agreement had temporarily lowered tariffs, offering a brief reprieve to global markets.

In a statement, China accused the U.S. of undermining the consensus by introducing “discriminatory and restrictive measures,” including export controls on AI chips and visa revocations for Chinese students. Trump, however, accused China of violating “a big part of the agreement” and expressed his intention to discuss the issue with Chinese President Xi Jinping.

The renewed tensions have dampened optimism for a lasting trade deal, with markets reacting negatively. Chinese stocks in Hong Kong fell sharply, led by declines in the Hang Seng Index and Hang Seng Tech Index.


Why It Matters?

The re-escalation of U.S.-China trade tensions highlights the fragility of the temporary truce and the challenges in reaching a lasting agreement. Key issues, such as technology export controls and rare-earth mineral exports, remain contentious, further complicating negotiations.

The market reaction underscores the economic stakes of the ongoing trade dispute. Declines in Chinese equities reflect investor concerns about the potential for prolonged uncertainty and its impact on global trade and economic growth.

Trump’s accusations and China’s counterclaims also signal a deepening mistrust between the two superpowers, raising questions about the feasibility of resolving broader geopolitical and economic tensions.


What’s Next?

President Trump’s planned discussion with Chinese President Xi Jinping will be closely watched for signs of progress or further escalation. Meanwhile, markets will monitor developments in U.S.-China relations, including potential retaliatory measures from Beijing.

Investors will also keep an eye on the impact of U.S. export controls and visa restrictions, as well as China’s response to Trump’s threat to double tariffs on steel and aluminum imports. The outcome of these disputes will shape the trajectory of global markets and trade dynamics in the coming months.

Source
Tags: China
Previous Post

Corporate Pension Funds Shift Strategies Amid Full Funding, Impacting Bonds and Private Equity

Next Post

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Recommended For You

US to Take 10% Stake in Trilogy Metals to Unlock Alaska Mining

by Team Lumida
3 hours ago
Trump Signs Sweeping Travel Ban on 12 Countries, Introduces Restrictions on 7 Others

Key Takeaways Powered by lumidawealth.com The U.S. government will acquire a 10% stake in Canadian minerals explorer Trilogy Metals Inc. through a $35.6 million investment aimed at securing critical...

Read more

Trump Open to Healthcare Talks With Democrats to End Shutdown

by Team Lumida
3 hours ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com President Trump expressed willingness to negotiate with Democrats on extending Affordable Care Act (ACA) subsidies amid the ongoing government shutdown, signaling potential progress toward...

Read more

US Gaza Plan Is Working, But Will Take Sustained Pressure

by Team Lumida
23 hours ago
US Gaza Plan Is Working, But Will Take Sustained Pressure

Key Takeaways Powered by lumidawealth.com The Trump administration’s plan has created diplomatic momentum and a realistic path for an initial hostage‑for‑prisoner swap, but broader settlement mechanics remain unresolved. Core...

Read more

China Secretly Funds Iranian Oil via Infrastructure

by Team Lumida
24 hours ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways Powered by lumidawealth.com Beijing is using a covert barter‑style conduit to pay Iran for crude: oil shipments to China are effectively financed by Chinese state‑backed contractors building...

Read more

Trump Pushes for Israel–Hamas Deal Ahead of Monday Talks

by Team Lumida
24 hours ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com The U.S. is pressing Israel and Hamas toward mediated talks in Sharm El‑Sheikh focused initially on a hostage‑for‑prisoner swap and a ceasefire framework. Core...

Read more

China Pushes Trump to Ease Security Curbs in Exchange for Investment

by Team Lumida
3 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Beijing has floated a proposal to the U.S. asking Washington to roll back national‑security barriers to Chinese investment in the U.S. in return for...

Read more

Lawsuit Challenges Trump’s $100,000 H‑1B Fee

by Team Lumida
3 days ago
Trump Delays Reciprocal Tariffs to August 1, Citing Progress in Trade Negotiations

Key Takeaways Powered by lumidawealth.com A coalition led by healthcare‑staffing firm Global Nurse Force and several labor unions filed suit in the Northern District of California to block the...

Read more

Trump Threatens Far‑Reaching Cuts at Federal Agencies

by Team Lumida
4 days ago
Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Key Takeaways Powered by lumidawealth.com The White House, led by OMB Director Russell Vought, is pursuing plans to use the government shutdown to impose large cuts and potentially dismiss...

Read more

World Food Prices Dip in September as Sugar and Dairy Ease

by Team Lumida
4 days ago
person standing between shelvings

Key Takeaways Powered by lumidawealth.com FAO food price index fell to 128.8 in September from an August revised 129.7, though still 3.4% above year‑ago levels and ~19.6% below the...

Read more

Trump Plans to Use Shutdown to Fire Federal Workers

by Team Lumida
5 days ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com White House OMB Director Russell Vought signaled imminent mass firings of federal workers as the administration leans into the government shutdown to shrink the...

Read more
Next Post
Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

AI Investment Boom: How Tech Giants Are Leading the Charge

AI Models Show Alarming Ability to Evade Human Control, Highlighting Urgent Need for Alignment Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

red 5-door hatchback in front of Burberry building

BMW’s Major Recall: 140,000 Mini Coopers at Risk!

September 3, 2024
China’s Central Bank Embraces Hedge Fund Tactics to Tame $4 Trillion Bond Market

China Rebuffs US Fentanyl Claims as New Trade War Escalates

February 5, 2025
top-view photography of houses at daytime

Homeownership Costs Skyrocket 26% Since Pandemic

June 10, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018